Restoring cellular differentiatin in posttransplant lymphoproliferative disease.
Amlot
P L
PL
Department of Immunology & Molecular Pathology, Royal & Free University College Medical School, London, UK. p.amlot@rfc.ucl.ac.uk
D001402:B-Lymphocytes / Q000187:drug effects / Q000502:physiology; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D002472:Cell Transformation, Viral; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005786:Gene Expression Regulation / Q000187:drug effects; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D006877:Hydroxamic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D016377:Organ Transplantation / Q000009:adverse effects*
D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; C107648:azelaic bishydroxamic acid